You can:
Name | Muscarinic acetylcholine receptor M2 |
---|---|
Species | Homo sapiens (Human) |
Gene | CHRM2 |
Synonym | cholinergic receptor AChR M2 M2 muscarinic acetylcholine receptor M2 receptor Chrm-2 [ Show all ] |
Disease | Urinary incontinence Heart failure Nausea; Addiction Parkinson's disease Peptic ulcer [ Show all ] |
Length | 466 |
Amino acid sequence | MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR |
UniProt | P08172 |
Protein Data Bank | 5zkc, 4mqs, 4mqt, 5yc8, 5zk3, 5zkb, 5zk8 |
GPCR-HGmod model | P08172 |
3D structure model | This structure is from PDB ID 5zkc. |
BioLiP | BL0433341, BL0433216, BL0263147, BL0263146, BL0263145, BL0433339, BL0433340, BL0433338 |
Therapeutic Target Database | T46185 |
ChEMBL | CHEMBL211 |
IUPHAR | 14 |
DrugBank | BE0000560 |
Name | carbachol |
---|---|
Molecular formula | C6H15ClN2O2 |
IUPAC name | 2-carbamoyloxyethyl(trimethyl)azanium;chloride |
Molecular weight | 182.648 |
Hydrogen bond acceptor | 3 |
Hydrogen bond donor | 1 |
XlogP | None |
Synonyms | NSC 32865 Rilentol SR-01000075312-6 Vasoperif NCGC00093705-01 [ Show all ] |
Inchi Key | AIXAANGOTKPUOY-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C6H14N2O2.ClH/c1-8(2,3)4-5-10-6(7)9;/h4-5H2,1-3H3,(H-,7,9);1H |
PubChem CID | 5831 |
ChEMBL | CHEMBL14 |
IUPHAR | N/A |
BindingDB | N/A |
DrugBank | DB00411 |
Structure | |
Lipinski's druglikeness | Partition coefficient log P of this ligand is not available. |
Parameter | Value | Reference | Database source |
---|---|---|---|
N/A | N/A | DrugBank | |
-logKa | 6.02 - | PMID16539379 | ChEMBL |
Activity | 1.0 - | PMID16539379 | ChEMBL |
Activity | 65.0 % | PMID13678406 | ChEMBL |
CCh | 100.0 % | Bioorg. Med. Chem. Lett., (1995) 5:6:637 | ChEMBL |
EC50 | 74.0 nM | PMID7783150 | ChEMBL |
EC50 | 110.0 nM | PMID7990109 | ChEMBL |
EC50 | 700.0 nM | PMID9873644, PMID10354408 | ChEMBL |
EC50 | 61000.0 nM | PMID9651157 | ChEMBL |
EC50 | 1.54882e+13 nM | PMID17084634 | ChEMBL |
ED50 | 22.8 nM | Bioorg. Med. Chem. Lett., (1995) 5:6:637 | ChEMBL |
ED50 | 270.0 nM | PMID9651157 | ChEMBL |
IC50 | 3.8 nM | PMID9873472 | ChEMBL |
IC50 | 12.59 nM | PMID13678406 | ChEMBL |
IC50 | 63.1 nM | PMID17149881 | ChEMBL |
IC50 | 130.0 nM | PMID9622546 | ChEMBL |
IC50 | 1400.0 nM | PMID9435896 | ChEMBL |
IC50 | 3100.0 nM | PMID9622546 | ChEMBL |
IC50 | 3460.0 nM | Bioorg. Med. Chem. Lett., (1992) 2:8:821 | ChEMBL |
IC50 | 119000.0 nM | PMID9651157 | ChEMBL |
Inhibition | 4.4 % | PMID9651157 | ChEMBL |
Inhibition | 58.0 % | Bioorg. Med. Chem. Lett., (1995) 5:6:631 | ChEMBL |
Intrinsic activity | 1.0 - | PMID17084634 | ChEMBL |
Ki | <10000.0 nM | PMID12235229 | PDSP |
Ki | 1.3 nM | PMID12747793 | PDSP |
Ki | 20.0 nM | PMID10891110, PMID9622546 | ChEMBL |
Ki | 38.0 nM | PMID10891110 | ChEMBL |
Ki | 100.0 nM | PMID17149881, PMID13678406 | ChEMBL |
Ki | 331.13 nM | PMID8968358 | PDSP |
Ki | 1230.27 nM | PMID24980056, PMID18543900, PMID19896386, PMID16539379, PMID18077164 | ChEMBL |
Ki | 1300.0 nM | PMID12747793 | ChEMBL |
Ki | 1318.26 nM | PMID18182302 | ChEMBL |
Ki | 1820.0 nM | PMID9454790 | PDSP |
Max | 100.0 % | PMID10354408 | ChEMBL |
Max cAMP | 100.0 % | PMID9873644 | ChEMBL |
pD2 | 7.33 - | PMID16539379, PMID17084634 | ChEMBL |
Ratio | 0.4 - | Bioorg. Med. Chem. Lett., (1991) 1:3:147 | ChEMBL |
Ratio | 9.0 - | PMID16539379 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417